Sign in

You're signed outSign in or to get full access.

Douglas Edwards

Director at Childrens PlaceChildrens Place
Board

About Douglas Edwards

Douglas R. Edwards, age 67, is an independent director at The Children’s Place (PLCE) since 2024; he serves on the Audit Committee and chairs the Corporate Responsibility, Sustainability & Governance (CRS&G) Committee. Edwards was Executive Vice President and Deputy General Counsel at Wells Fargo overseeing the Global Commercial and Securities Division; earlier roles include legal leadership positions at First Union/Wachovia and commercial litigation at Hodgson, Russ, Andrews, Woods & Goodyear. He holds a B.A. (University of Virginia, 1979), M.A. in history (University of Kentucky, 1985), and J.D., cum laude (University of Buffalo, 1985) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Wells FargoEVP & Deputy General Counsel; led Global Commercial & Securities DivisionNot disclosedSenior legal leadership overseeing financial/legal risk
First Union / WachoviaVarious legal division rolesNot disclosedCorporate legal leadership
Hodgson, Russ, Andrews, Woods & Goodyear (Buffalo)Commercial litigator (bankruptcy, financial institutions)Not disclosedSpecialty in bankruptcy litigation and financial institution representation

External Roles

OrganizationRoleTenureNotes
No other public company directorships disclosed in proxy biographies .

Board Governance

  • Committee assignments (early fiscal 2025): Edwards chairs CRS&G and is a member of the Audit Committee; Audit Committee chaired by Hussan Arshad; CRS&G members include Edwards, Arshad, and Asif Seemab .
  • Attendance: In fiscal 2024, the Board held 19 meetings; Audit 7; CRS&G 8; Human Capital & Compensation (HC&C) 5; “All directors, all meetings” for each body (no absences) .
  • Independence: Edwards is identified as an independent director; Audit Committee independence and financial sophistication are affirmed annually per SEC/NASDAQ standards .
  • Controlled company status: Following a change in control, PLCE relies on NASDAQ controlled company exceptions (e.g., not requiring a majority independent Board and fully independent HC&C and CRS&G) .
  • Shareholder engagement: Board practices include proxy access, majority voting in uncontested elections, and executive sessions without management; CRS&G leads nominations and shareholder-recommended candidates evaluation .

Committee Memberships (current as disclosed)

CommitteeRoleMembers
Corporate Responsibility, Sustainability & Governance (CRS&G)ChairDouglas Edwards (Chair); Hussan Arshad; Muhammad Asif Seemab
Audit CommitteeMemberHussan Arshad (Chair); Douglas Edwards; Rhys Summerton (2025 update)
Human Capital & Compensation (HC&C)Muhammad Asif Seemab (Chair); Turki AlRajhi; Hussan Arshad

Fixed Compensation

MetricFY 2024Notes
Fees Earned or Paid in Cash ($)84,788Pro-rated from March 14, 2024 appointment
Stock Awards ($)125,047TRSUs, grant date fair value per ASC 718
Total ($)209,835Sum of cash + equity

Director compensation program (FY 2024 settings):

  • Annual cash retainer: $70,000 .
  • Annual equity grant: $140,000 in time-vested RSUs (TRSUs) for directors; $190,000 for Chairman; grants generally vest after one year on first business day of fiscal year; plan cap $250,000 per calendar year .
  • Additional annual cash retainers: Chairman $100,000; Audit Chair $30,000; HC&C Chair $25,000; CRS&G Chair $25,000; Committee member retainers: Audit $15,000; HC&C $12,500; CRS&G $10,000 .
  • No per-meeting fees disclosed; compensation structured as retainer plus equity .

Performance Compensation

Director equity is time-based (TRSUs) with no disclosed performance metrics (no PSUs or options for directors). Grant details below:

Grant TypeGrant DateShares GrantedGrant-Date Fair Value ($)VestingSource
TRSUs (Director annual grant)2024-03-149,531125,047Time-vested; generally 1-yearForm 4, 2024-03-18; 2025 proxy table (SEC: https://www.sec.gov/Archives/edgar/data/1041859/000110465924035589/0001104659-24-035589-index.htm)
TRSUs (Director annual grant)2025-02-1814,493Not yet vested (as of 2025-04-08)Form 4, 2025-02-20; proxy footnote (SEC: https://www.sec.gov/Archives/edgar/data/1041859/000110465925015814/0001104659-25-015814-index.htm)

Notes:

  • Fair value methodology: closing price on grant date per ASC 718; awards to individuals at retirement age may be subject to accelerated expensing for reporting .
  • Company-selected executive performance measures (context for HC&C oversight): Net Income, Adjusted Operating Income, Adjusted Free Cash Flow (for PVP disclosures; not applied to director pay) .

Other Directorships & Interlocks

CategoryDetails
Current public company boardsNone disclosed for Edwards
InterlocksNone disclosed; CRS&G chair role includes oversight of governance and related person transaction approvals
Notable affiliations on PLCE BoardMithaq-affiliated directors (Executive Chairman AlRajhi; Vice Chairman Seemab) and controlled company status; HC&C and CRS&G may include non-independent members under exceptions

Expertise & Qualifications

  • Financial/legal risk oversight: Former EVP & Deputy GC at a major financial institution; experience spans commercial and securities law and bankruptcy litigation .
  • Governance and ESG oversight: Chairs CRS&G, with mandate over ESG/governance risks and nominations .
  • Audit oversight: Member of Audit Committee; committee report signed by Arshad (Chair), Edwards, and Summerton in 2025; similar 2024 report signed by Arshad, Umair, Edwards .

Equity Ownership

ItemValueDateNotes
Shares beneficially owned9,5312025-04-08<1.0% of outstanding shares; excludes 14,493 TRSUs not yet vested
Unvested TRSUs14,493Granted 2025-02-18Not yet vested as of ownership table date
Ownership guidelines5x annual cash retainer5-year compliance windowNon-employee directors must reach 5x cash retainer within five years
Hedging/pledgingProhibitedPolicy-levelCompany prohibits hedging and pledging of Company stock

Insider Trades (Form 3/4)

Filing DateTransaction DateFormTypeSharesPost-Transaction OwnershipSEC Filing
2024-03-182024-03-14Form 3Initialhttps://www.sec.gov/Archives/edgar/data/1041859/000110465924035580/0001104659-24-035580-index.htm
2024-03-182024-03-14Form 4A (Award – TRSUs)9,5319,531https://www.sec.gov/Archives/edgar/data/1041859/000110465924035589/0001104659-24-035589-index.htm
2025-02-202025-02-18Form 4A (Award – TRSUs)14,49324,024https://www.sec.gov/Archives/edgar/data/1041859/000110465925015814/0001104659-25-015814-index.htm

Source: Insider-trades skill output; “securitiesOwned” reflects post-transaction positions (more current than proxy tables).

Governance Assessment

  • Positives:

    • Independent status, strong legal/financial oversight experience; chairs CRS&G and sits on Audit—positions central to governance quality and risk oversight .
    • Full attendance across Board and committees in fiscal 2024; high engagement signals .
    • Alignment mechanisms: annual TRSUs; stock ownership guidelines (5x cash retainer over five years); hedging/pledging prohibitions reduce misalignment risk .
  • Watch items / potential red flags:

    • Controlled company reliance: Board has chosen NASDAQ “controlled company” exceptions—HC&C and CRS&G need not be fully independent; this can dilute minority shareholder protections even with Edwards as CRS&G Chair .
    • Related-party transactions with controlling shareholder (Mithaq): CRS&G approves these (credit facility; rights offering with debt forgiveness); Edwards’ committee leadership increases the importance of rigorous process and fairness review .
    • Concentrated control: Mithaq holds ~62.2% of shares, enabling unilateral outcomes on shareholder approvals (including written consent proposals), elevating governance risk perceptions despite committee oversight .

Overall, Edwards’ legal-risk background and committee leadership bolster governance effectiveness; however, PLCE’s controlled company status and material related-party dealings require heightened scrutiny of CRS&G processes to maintain investor confidence .